Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
NCT05320367Phase 2Not yet recruiting
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cannabidiol, sponsored by Centre hospitalier de l’Université de Montréal. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NCT05320367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320367.